Only approved oral, single agent, targeted therapy for these patients following platinum-based chemotherapy.
CU Anschutz
Anschutz Cancer Pavilion
1665 North Aurora Court
2004
Aurora, CO 80045
ZEGFROVY® (sunvozertinib) now available in the US for patients with previously treated non-small cell lung cancer with EGFR exon 20 insertion mutations
minute read
by BioSpace | October 22, 2026
